Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 E Main St
Rexburg, ID 83440Phone+1 208-359-6900Fax+1 208-359-6489- Is this information wrong?
Education & Training
- Indiana University – Purdue University IndianapolisM.B.A., Business of Medicine Program, 2015 - 2017
- University of Utah HealthFellowship, Hematology and Medical Oncology, 2012 - 2015
- University of MarylandResidency, Internal Medicine, 2008 - 2011
- University of Florida College of MedicineClass of 2008
- University of FloridaB.S., Major: Basic Biology and Medicine; Minor: Business Administration, 2001 - 2004
- University of FloridaA.A., 2001 - 2003
Certifications & Licensure
- UT State Medical License 2012 - 2026
- ID State Medical License 2017 - 2024
- MD State Medical License 2011 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Anderson Scholar University of Florida College of Liberal Arts and Sciences, 2004
- Junior Honors Medical Program University of Florida College of Medicine, 2003
- Presidential Ceremony Honoree University of Florida, 2003
- Join now to see all
Publications & Presentations
PubMed
- Keeping a track on leptomeningeal disease in non-small cell lung cancer: A single-institution experience with CNSide.Monynahan, K., Cannon, L., Blouw, B., Puri, S., Malani, R., Chalmers, A., Kerrigan, K., Patel, S., Akerley, W.> ;Neuro-Oncology Advances. 2023 Dec 9
- Synergistic Toxicities from Multiple Therapies for Synchronous Malignancies.Shiven B Patel, Katerina Butler, John Esther, Jenny Tuan> ;Case Reports in Oncology. 2023 Feb 6
- Real-world comparison of survival outcomes with cisplatin versus carboplatin in patients with limited-stage small-cell lung cancer.Shashank Sama, Kathleen Kerrigan, Jennifer A Sinnott, Sonam Puri, Wallace Akerley, Benjamin Haaland, Shiven Patel> ;Cancer Treatment and Research Communications. 2023 Jan 1
- Join now to see all
Journal Articles
- Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinomaKuzman JA, Stenehjem DD, Merriman J, Agarwal AM, Patel SB, Hahn AW, Alex A, Albertson D, Gill DM, Agarwal N, BMC Urology, 1/1/2017
- Effect of treatment dose reductions in the setting of hand-foot syndrome on survival outcomes in patients with metastatic renal cell carcinoma treated with vascular en...Bailey EB, Merriman J, Maughan B, Poole A, Tantravahi SK, Agarwal AM, Batten JA, Patel SB, Pal SK, Stenehjem DD, Agarwal N, Journal of Oncology Pharmacy Practice, 1/1/2017
- Myeloid Growth Factors, Version 22017, NCCN Clinical Practice Guidelines in OncologyCrawford J, Becker PS, Armitage JO, Blayney DW, Chavez J, Curtin P, Dinner S, Fyan T, Gojo I, Griffiths EA, Hough S, Kloth DD, Kuter DJ, Lyman GH, Mably M, Mukherjee S..., Journal of the National Comprehensive Cancer Network, 1/1/2017
- Join now to see all
Abstracts/Posters
- Association of time from definitive therapy (DT) to start of androgen deprivation therapy (ADT) for metastatic disease and survival outcomes in men with new metastatic...Gill DM, Stenehjem DD, Cheng HH, Kessler ER, Hahn AW, Gupta S, Alex A, Patel SB, Chittoria N, Twardowski P, Vaishampayan UN, Agarwal N, Journal of Clinical Oncology, 1/1/2017
- Association of single nucleotide polymorphisms (SNPs) in STS and SULT2B1 and response to androgen deprivation therapy (ADT) in men with advanced hormone sensitive pros...Agarwal N, Buckley TH, Farnham JM, Patel SB, Agarwal A, Tantravahi SK, Teerlink C, Albright FS, Stephenson RA, Alex A, Cannon-Albright LA, Clinical Cancer Research, 1/1/2016
- Association of single nucleotide polymorphisms (SNPs) in TPD52 gene with response to treatment with enzalutamide (ENZA) in men with metastatic castration refractory pr...Agarwal N, Heemers H, Farnham JM, Patel SB, Gill DM, Gupta S, Teerlink C, Stephenson RA, Alex A, Cannon-Albright LA, Journal of Clinical Oncology, 1/1/2016
- Join now to see all
Lectures
- Risk stratification using patient-reported outcomes (PROs) in patients (pts) with advanced cancer.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- Oncologic Emergencies1/1/2018
- Lung CancerVeterans Affairs Hospital, University of Utah - 1/1/2017
- Join now to see all
Press Mentions
- The Biggest Reimbursement Challenges in Oncology: 6 Leaders Weigh InDecember 7th, 2020
- Navigating Treatment Decisions with Immunotherapy in Squamous NSCLCOctober 11th, 2019
- Conference Coverage: NCCN Policy SummitAugust 17th, 2019
- Join now to see all
Hospital Affiliations
- MadisonHealthRexburg, Idaho
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: